 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/03/2026 |
$17.19 |
$17.22 |
$16.83 |
$16.83 |
3.15M | | 08/04/2026 |
$16.35 |
$16.68 |
$16.30 |
$16.56 |
5.91M | | 08/05/2026 |
$16.66 |
$16.78 |
$16.57 |
$16.72 |
4.87M | | 08/06/2026 |
$17.07 |
$17.28 |
$16.91 |
$17.02 |
4.27M | | 08/07/2026 |
$17.48 |
$17.56 |
$17.41 |
$17.45 |
4.23M |
 |
| Takeda Pharmaceutical is a biopharmaceutical company with an innovative portfolio, engaged primarily in the research, development, production and marketing of pharmaceutical products. Co. has a geographically diversified global business and provides its prescription drugs in Japan and overseas. Co.'s principal pharmaceuticals are antidiabetic, antihypertensive medicine, drugs for multiple myeloma and mantle cell lymphoma, medicine for reflux esophagitis, and hyperuricemia treatment. Co. focuses its R&D activities on four core therapeutic areas of oncology, rare genetics and hemotology, neuroscience, gastroenterology, plasma-derived therapies and vaccines. | |
 |

Takeda Pharmaceutical (TAK) has the following price history information. Looking back at TAK historical stock prices for the last five trading days, on August 03, 2026, TAK opened at $17.19, traded as high as $17.22 and as low as $16.83, and closed at $16.83. Trading volume was a total of 3.15M shares. On August 04, 2026, TAK opened at $16.35, traded as high as $16.68 and as low as $16.30, and closed at $16.56. Trading volume was a total of 5.91M shares. On August 05, 2026, TAK opened at $16.66, traded as high as $16.78 and as low as $16.57, and closed at $16.72. Trading volume was a total of 4.87M shares. On August 06, 2026, TAK opened at $17.07, traded as high as $17.28 and as low as $16.91, and closed at $17.02. Trading volume was a total of 4.27M shares. On August 07, 2026, TAK opened at $17.48, traded as high as $17.56 and as low as $17.41, and closed at $17.45. Trading volume was a total of 4.23M shares.
TAK Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Takeda Pharmaceutical shares, starting with a $10,000 purchase of TAK, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
08/11/2016 |
|
| End date: |
08/07/2026 |
|
| Start price/share: |
$23.54 |
|
| End price/share: |
$17.45 |
|
| Starting shares: |
424.81 |
|
| Ending shares: |
453.60 |
|
| Dividends reinvested/share: |
$0.96 |
|
| Total return: |
-20.85% |
|
| Average Annual Total Return: |
-2.31% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,916.93 |
|
| Years: |
9.99 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/11/2016 |
|
| End date: |
08/07/2026 |
|
| Start price/share: |
$23.54 |
|
| End price/share: |
$17.45 |
|
| Dividends collected/share: |
$0.96 |
|
| Total return: |
-21.81% |
|
| Average Annual Total Return: |
-2.43% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,820.27 |
|
| Years: |
9.99 |
|
|
 |
| Date |
Close |
| 08/03/2026 | $16.83 | | 08/04/2026 | $16.56 | | 08/05/2026 | $16.72 | | 08/06/2026 | $17.02 | | 08/07/2026 | $17.45 |
|
 |